Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
ARIA, ARRY, now AUPH!
I'm not selling any AUPH yet, waiting to see how this plays out. Hopefully another buyout!
Next for me is APTO, have been accumulating
(Even my blood type is A)
We won
Are you joking?!
AURORA status updated to "Completed" at
https://clinicaltrials.gov/ct2/show/NCT03021499
Exactly! Those who create fear, uncertainty and doubt in those who haven't put in the work to know what they own.
It seems that whomever needed to buy in in 4s has completed their accumulation.
Absolutely correct. Hormesis is a thing.
Ok. So they invested because they think that the stock is going to go down?!
It's ok. They know best how much they need. They may have the opportunity to raise more, if necessary, at substantially higher prices very shortly.
"#FAIL"
Grade A histrionics there BR. Pull it together.
Cervelo, how the $#*" are you down 40%?! Want to lower your cost basis? Here's your opportunity
Every biotech in my portfolio is down, some even more than AUPH. Biotech is out of favor. This has nothing to do with AURORA. Keep your head in the game.
I feel like that chart today is giving us the middle finger ??
Seems like the DSMB would have stopped the trial by now if there were a significant number of patient deaths.
I have always thought of having the Aspreva crew back together as a feature, not a bug
Speaking of Clackson, in case you haven't heard:
http://akrevia.com/#team
Why? If VOS crashes and burns and we get the opportunity to buy in the 4s I would consider it a gift from above. Keep your eyes on the prize!
Of course, even better if VOS succeeds, but I'm cool either way
Glickman is playing the shorts masterfully with this "ahead of schedule" schtick. He knows exactly what he is going to have and when he is going to have it. Shorts are used to bumbling biotech CEOs who are all hype and bluster, hopefully they have learned their lesson about AUPH now.
First, this company underpromises and over delivers time again. It won't take 15 months. Second, it will take >12 months for sure. The endpoint is at 52 weeks and you can expect 4-6 weeks minimum to analyze the data. I think that we'll have it between Halloween and Thanksgiving next year. Cheers!
Strong finish today. Run up to the Feb update should be interesting
I noticed that the Dec 17 presentation on the Aurinia website says 167 sites initiated (Slide 26). Seems like CT.gov lags
Thank you for this and all of the insight you share on this board
I have a quick follow up thought on that:
My fear (irrational, I hope) is that, with a healthier study population, the comparator group might perform better in Ph3 than they did in Ph2.
It would be interesting to see an analysis of the Ph2 data excluding the questionable sites.
Holding his phone upside down?
Lol, that's the spirit!
How many shares does Duggan own?
One year from now we'll have impending data on FSGS/MCD and DES and initiation of rolling NDA.
Sounds great to me. Time to go back to sleep.
You want excitement, watch CWBR
Everything's coming up EXEL!
No debt, expanding indications (aka revenue).
Looking forward to hearing what they're looking at re: in-licensing/pipeline
BMY success does not mean EXEL failure. They are our friends.
Future is Cabo + Opdivo + Yervoy
Nice close
Oh no, not again! I hope he has learned to leave the live TV to the pros! Fall update should be better, he will own the stage and control the message better.
I don't include Cramer in the same class as medical conferences and investor conferences. Can't stand his antics and I am baffled that he has as much credibility as he apparently has.
Glickman did not help the stock by doing this interview at all. Unless he has something positive to announce, investors would be better off if he just kept a lid on it.
Typical pump and dump. What's in it for AUPH for Glickman to appear on Cramer?! He got played and some WS sleazeballs made some money. It's a non-event for investors, back to the 6s.
Ooh! That news release got my pulse racing for just a minute until I had time to read it through. Who says this stock has become boring?! ;)
I like it! Good volume too
"Each Reporting Person has ceased to beneficially own five percent (5%) or more of the Issuer’s outstanding Common Stock."
Deerfield notes RIP
EXEL just keeps executing
Up next, quarterly report with growing revenue and profits and HCC/RCC updates this Fall
It's great to be a winner
Nice! Next up, Deerfield notes paid up